On Tuesday, a number of major players will release their results before the opening bell, including Home Depot (HD), the leading home improvement retailer, and AstraZeneca (AZN), the multinational ...
In the coming truncated week, the markets are expected to consolidate further with stock-specific action due to global ...
We recently compiled a list of the 10 Best UK Stocks to Invest in Now. In this article, we are going to take a look at where ...
The company confirmed that Leon Wang, head of its Chinese arm, was being detained while two other executives, as well as two ...
Six months after Amgen and AstraZeneca reported promising results for Tezspire (t | A phase 3 study has shown that ...
The Philadelphia Phillies recently raised close to $500 million in capital from three new investors, according to two people ...
1d
AstraZeneca and Viking Therapeutics both presented encouraging data on their obesity pills. Meanwhile, here’s how Americans ...
Results from the Phase III WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps showed that AstraZeneca (AZN) and ...
AstraZeneca and Amgen's drug could have a new use after positive Phase 3 study results. Elsewhere, Jazz set new plans for a ...
AstraZeneca and Amgen's Phase 3 trial data shows Tezspire significantly reduces nasal polyps and congestion in patients with chronic rhinosinusitis with nasal polyps.
GlobalData on MSN1d
AstraZeneca and Amgen’s Tezspire succeeds in Phase III nasal polyps trialThe companies’ monoclonal antibody met co-primary endpoints in a Phase III trial in patients with chronic rhinosinusitis with ...
Leerink Partners analyst Andrew Berens has maintained their bullish stance on AZN stock, giving a Buy rating on November 6. Andrew ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback